FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Premarin (conjugated estrogens) from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Postmenopausal Osteoporosis
• Vasomotor Symptoms of Menopause

Drugs mentioned

• PREMARIN (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN (CONJUGATED ESTROGENS)